Stocks in Play

MethylGene Inc.

03:54 PM EST - MethylGene Inc. : shares plunged cents after it suspended enrolment of patients into clinical trials of its treatment for Hodgkin's lymphoma. MethylGene Inc. shares T.MYG are trading off 82 cents at $0.99.